» Articles » PMID: 33741054

Evaluation of a Multidisciplinary Lipid Clinic to Improve the Care of Individuals with Severe Lipid Conditions: a RE-AIM Framework Analysis

Overview
Publisher Biomed Central
Specialty Health Services
Date 2021 Mar 20
PMID 33741054
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Individuals with complex dyslipidemia, or those with medication intolerance, are often difficult to manage in primary care. They require the additional attention, expertise, and adherence counseling that occurs in multidisciplinary lipid clinics (MDLCs). We conducted a program evaluation of the first year of a newly implemented MDLC utilizing the RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) framework to provide empirical data not only on program effectiveness, but also on components important to local sustainability and future generalizability.

Methods: The purpose of the MDLC is to increase the uptake of guideline-based care for lipid conditions. Established in 2019, the MDLC provides care via a centralized clinic location within the healthcare system. Primary care providers and cardiologists were invited to refer individuals with lipid conditions. Using a pre/post-study design, we evaluated the implementation outcomes from the MDLC using the RE-AIM framework.

Results: In 2019, 420 referrals were made to the MDLC (reach). Referrals were made by 19% (148) of the 796 active cardiology and primary care providers, with an average of 35 patient referrals per month in 2019 (SD 12) (adoption). The MDLC saw 83 patients in 2019 (reach). Additionally, 50% (41/82) had at least one follow-up MDLC visit, and 12% (10/82) had two or more follow-up visits in 2019 (implementation). In patients seen by the MDLC, we found an improved diagnosis of specific lipid conditions (FH (familial hypercholesterolemia), hypertriglyceridemia, and dyslipidemia), increased prescribing of evidence-based therapies, high rates of medication prior authorization approvals, and significant reductions in lipid levels by lipid condition subgroup (effectiveness). Over time, the operations team decided to transition from in-person follow-up to telehealth appointments to increase capacity and sustain the clinic (maintenance).

Conclusions: Despite limited reach and adoption of the MDLC, we found a large intervention effect that included improved diagnosis, increased prescribing of guideline-recommended treatments, and clinically significant reduction of lipid levels. Attention to factors including solutions to decrease the large burden of unseen referrals, discussion of the appropriate number and duration of visits, and sustainability of the clinic model could aid in enhancing the success of the MDLC and improving outcomes for more patients throughout the system.

Citing Articles

Learnings from Implementation Strategies to Improve Lipid Management.

Lan N, Chen R, Dwivedi G, Watts G, Nicholls S, Nelson A Curr Cardiol Rep. 2025; 27(1):9.

PMID: 39775142 PMC: 11711772. DOI: 10.1007/s11886-024-02174-8.


Increasing provider awareness of Lp(a) testing for patients at risk for cardiovascular disease: A comparative study.

Eid W, Sapp E, Conroy C, Bessinger C, Moody C, Yadav R Am J Prev Cardiol. 2024; 21:100895.

PMID: 39720768 PMC: 11666892. DOI: 10.1016/j.ajpc.2024.100895.


Closing the Gaps in Care of Dyslipidemia: Revolutionizing Management with Digital Health and Innovative Care Models.

Apple S, Clark R, Daich J, Gonzalez M, Ostfeld R, Toth P Rev Cardiovasc Med. 2024; 24(12):350.

PMID: 39077078 PMC: 11272850. DOI: 10.31083/j.rcm2412350.


Evaluation of multidisciplinary high-risk pregnancy clinic for myelomeningocele.

Anderson L, Hopson B, Caudill C, Rocque B, Blount J, Arynchyna-Smith A Childs Nerv Syst. 2024; 40(8):2505-2514.

PMID: 38644383 PMC: 11269498. DOI: 10.1007/s00381-024-06337-4.


International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia.

Watts G, Gidding S, Hegele R, Raal F, Sturm A, Jones L Nat Rev Cardiol. 2023; 20(12):845-869.

PMID: 37322181 DOI: 10.1038/s41569-023-00892-0.


References
1.
Nhim K, Gruss S, Porterfield D, Jacobs S, Elkins W, Luman E . Using a RE-AIM framework to identify promising practices in National Diabetes Prevention Program implementation. Implement Sci. 2019; 14(1):81. PMC: 6694543. DOI: 10.1186/s13012-019-0928-9. View

2.
Nilsen P . Making sense of implementation theories, models and frameworks. Implement Sci. 2015; 10:53. PMC: 4406164. DOI: 10.1186/s13012-015-0242-0. View

3.
Tabak R, Khoong E, Chambers D, Brownson R . Bridging research and practice: models for dissemination and implementation research. Am J Prev Med. 2012; 43(3):337-50. PMC: 3592983. DOI: 10.1016/j.amepre.2012.05.024. View

4.
Proctor E, Powell B, McMillen J . Implementation strategies: recommendations for specifying and reporting. Implement Sci. 2013; 8:139. PMC: 3882890. DOI: 10.1186/1748-5908-8-139. View

5.
Shaffer J, Wexler L . Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care. Arch Intern Med. 1995; 155(21):2330-5. View